On November 8, 2024, Roche Diagnostics enhanced the company's long term commitment to China's local healthcare industry, to ultimately benefit patients in China and beyond, with the opening of its new Roche Diagnostics Head Office in China.
Alongside opening the new offices, Roche Diagnostics capabilities in China have been further recognised as it has been granted the Group Open Innovation (GOI) initiative certification by the Pudong New Area for its Technical Innovation Center (TIC).
Matt delivering a short note after receiving the certification. [Photo provided to chinadaily.com.cn]
Matt Sause, CEO of Roche Diagnostics, stated: "Supporting delivery of sustainable healthcare in China is a major priority for Roche Diagnostics. The country's embrace of innovative solutions to improve the lives of its people makes it an ideal partner to Roche Diagnostics. We have invested to establish our entire value chain in China to optimally deliver care to the patients that can benefit from our solutions."
The TIC will help Roche Diagnostics accelerate cooperation in fields such as clinical validation, the transformation of new in vitro diagnostic (IVD) technologies, the application of digital and innovative diagnostic solutions, the commercialization of IVD products, and accelerating companion diagnostics cooperation.
Pudong New Area has established an innovative ecosystem that supports the biopharmaceutical industry in their development of advanced medical solutions. In July 2021, the Pudong New Area officially introduced the Group Open Innovation (GOI) initiative. The GOI has evolved into an integrated ecosystem that brings together government entities, industry stakeholders, educational institutions, research organizations, and financial service providers. It aims to provide the resources and global network advantages of large enterprises, help bring SME and tech start-ups into the innovation chain and promote the upgrading of R&D centers to open innovation centers.
Roche Diagnostics has a long presence in China and the new head office in the Pudong New Area further demonstrates the company's long-term commitment to be "In China, For China". The office incorporates the design concepts of flexible working, diversity and inclusion, and sustainable development, creating a vibrant, open, and collaborative modern office space that continually empowers business innovation and development. Roche Diagnostics aims to leverage the rich biopharmaceutical industry ecosystem and high-quality openness of Pudong New Area to accelerate the rollout of globally leading diagnostic solutions in China, benefiting Chinese patients.
Richard Yiu, General Manager of Roche Diagnostics China, stated: "I am delighted that Roche Diagnostics officially joined the GOI club today. Receiving the GOI certification at the important inauguration moment of Roche Diagnostics China's new head office is truly a double celebration. This not only is a high recognition of Roche Diagnostics' innovative strength but also motivates us to further create sustainable value for patients through a new model and through an 'in China, for China' strategy. Standing at this new starting point, Roche Diagnostics China will continue to deepen its presence in the Chinese market and grow together with Healthy China as a local innovation driver, and collaboratively pursue a sustainable health future with all partners."
General manager of Roche Diagnostics China Richard Yiu giving a speech. [Photo provided to chinadaily.com.cn]
